[1]
Kumar, B. 2018. RESVERATROL INHIBITS EXPRESSION OF CANCER-SPECIFIC PENTOSE PHOSPHATE PATHWAY ENZYME TKTL1. Asian Journal of Pharmaceutical and Clinical Research. 11, 6 (Jun. 2018), 332–335. DOI:https://doi.org/10.22159/ajpcr.2018.v11i6.25021.